Sfoglia per AUTORE
MASSAIA M
Collezione AOU Alessandria

  

Items : 12

A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas. in Blood cancer discovery / Blood Cancer Discov. 2024 Sep 3;5(5):318-330. doi: 10.1158/2643-3230.BCD-24-0052.
2024
AOU Alessandria
AOU Città della Salute di Torino

Massaia M; Cavallo F; Ladetto M; Olivieri J; Krampera M; Grillo G; Russo D; Musso M; Barbui AM; Botto B; Sorà F; Santoro A; Bonifazi F; Dodero A; Martino M; Carrabba MG; Cutini I; Tisi MC; Di Rocco A; Chiusolo P; Ljevar S; Bramanti S; Casadei B; Stella F; Chiappella A; Arcaini L; Pennisi M; Zinzani PL; Miceli R; et alii...

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma
2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia. in British journal of haematology / Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20.
2023
AOU Alessandria
AOU Città della Salute di Torino

Corradini P; Passamonti F; Bertù L; Pulsoni A; Rivela P; Massaia M; Busca A; Falini B; Della Porta MG; Vallisa D; Cattaneo C; Capponi M; Bruna R; Tisi MC; Selleri C; Gozzetti A; Broccoli A; De Carolis L; Morotti A; Romano A; D'Elia GM; Candoni A; Marchetti M; Mancini A; Tiacci E;

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.
2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Visco C; Corradini P; Passamonti F; Bertù L; Gherlinzoni F; Pagano L; Guidetti A; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Coviello E; Della Porta MG; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Massaia M; Bocchia M; Billio A; Cattaneo C; Derenzini E; Scattolin A; Marchesi F; Fracchiolla NS; Arcaini L; Trentin L; et alii...

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients. in British journal of haematology / Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.
2022
AOU Alessandria
AO Cuneo
AOU Novara

Gariglio M; Gaidano G; Massaia M; Ladetto M; Pistello M; Lai M; Rapezzi D; Marchetti M; Gaidano V; Ucciero MAM; Mahmoud AM; Patriarca A; Ferrante D; De Andrea M; Martuscelli L; Griffante G; Bruna R; Borgogna C;

2022
AOU Alessandria
AO Cuneo
AOU Novara

Gariglio M; Massaia M; Gaidano G; Ladetto M; Lai M; Pistello M; Rapezzi D; Marchetti M; Mahmoud AM; Gaidano V; Patriarca A; Ferrante D; Borgogna C; Bruna R; Griffante G; Martuscelli L; De Andrea M;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Merli F; Passamonti F; Candoni A; Krampera M; Venditti A; Selleri C; Tosi P; Lanza F; Conconi A; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Rigacci L; Armiento D; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Corso A; Cilloni D; Cardinali V; Turrini M; Trentin L; Cuneo A; Della Porta M; Massaia M; Fracchiolla N; et alii...

Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):857-863. doi: 10.1002/hon.3060. Epub 2022 Aug 14.
2022
AOU Alessandria

Lanza F; Monaco F; Ciceri F; Cairoli R; Sacchi MV; Guidetti A; Marchetti M; Massaia M; Arcaini L; Krampera M; Mohamed S; Gherlinzoni F; Mecucci C; Gentile M; Romano I; Venditti A; Ruggeri M; Ferrero D; Coviello E; Fabbri E; Corradini P; Passamonti F;

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.
2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Grossi PA; Bertù L; Zaja F; Musto P; Petrucci L; Lanza F; Visani G; Mina R; La Barbera EO; Cattaneo C; Candoni A; Krampera M; Luppi M; Cardinali V; Galimberti S; Armiento D; Bocchia M; Marchesi F; Fracchiolla N; Tafuri A; Pinto A; Arcaini L; Massaia M; Ladetto M; Busca A; Venditti A; Farina F; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up. in British journal of haematology / Br J Haematol. 2018 Jun;181(5):693-695. doi: 10.1111/bjh.14681. Epub 2017 Apr 2.
2018
AOU Alessandria

Ghione P; Genuardi E; Rossi D; Drandi D; Mantoan B; Barbero D; Bernocco E; Monitillo L; Cerri M; Ruggeri M; Omede P; Deambrogi C; De Paoli L; Passera R; Coscia M; Cavallo F; Massaia M; Boccadoro M; Gaidano G; Ladetto M; Ferrero S;